Cite
Integration of scRNA-Seq and Bulk RNA-Seq to analyze the heterogeneity of colorectal cancer immune cells and establish a molecular risk model.
MLA
Li-Yue Sun, et al. “Integration of ScRNA-Seq and Bulk RNA-Seq to Analyze the Heterogeneity of Colorectal Cancer Immune Cells and Establish a Molecular Risk Model.” TMR Cancer - Cancer Advances, vol. 6, Jan. 2023, pp. 1–10. EBSCOhost, https://doi.org/10.53388/2023623022.
APA
Li-Yue Sun, Jiao-Jiao Yang, Xin-Xin Zeng, Yu-Ying Jiang, Ju Shen, Fang Wang, & Xu-Hui Zhang. (2023). Integration of scRNA-Seq and Bulk RNA-Seq to analyze the heterogeneity of colorectal cancer immune cells and establish a molecular risk model. TMR Cancer - Cancer Advances, 6, 1–10. https://doi.org/10.53388/2023623022
Chicago
Li-Yue Sun, Jiao-Jiao Yang, Xin-Xin Zeng, Yu-Ying Jiang, Ju Shen, Fang Wang, and Xu-Hui Zhang. 2023. “Integration of ScRNA-Seq and Bulk RNA-Seq to Analyze the Heterogeneity of Colorectal Cancer Immune Cells and Establish a Molecular Risk Model.” TMR Cancer - Cancer Advances 6 (January): 1–10. doi:10.53388/2023623022.